May 9, 2022. This new article published in the Journal of Clinical Immunology reports on 47 Brazilian patients who were investigated for SCID between 2009-2020. The diagnosis rate of SCID in Brazil improved throughout the duration of the pilot programs; however, investigators estimate that at least 80% of SCID cases in Brazil remain undiagnosed. As of May 2021, São Paulo universally implemented NBS-SCID, and investigators hope that other large cities in Brazil will follow, resulting in earlier diagnosis, and an increased survival rate of SCID patients.
Read more here: SCID and Other Inborn Errors of Immunity with Low TRECs – the Brazilian Experience.